Table 5 Values for inflammation and muscle-damage markers measured before and after 6 weeks of neuromuscular (NMT) or endurance-dominated (ET) training (means ± SDs)
Variables | Group | Pre | Post | Change % | Cohen’s d | ANOVA p-value (Cohen’s d) | ||
|---|---|---|---|---|---|---|---|---|
Time | Group | Interaction | ||||||
CRP (mg/L) | ET | 0.84 ± 0.23 | 2.07 ± 1.07 | 146.43 | 0.85 | < 0.001(2.92) | 0.721(0.16) | 0.803(0.11) |
|  | NMT | 0.87 ± 0.36 | 2.20 ± 0.79 | 152.87 | 0.98 |  |  |  |
IL-6 (pg/mL) | ET | 0.99 ± 0.15 | 4.43 ± 1.52 | 347.47 | 1.83 | < 0.001(0.96) | 0.008(0.28) | 0.005(0.31) |
|  | NMT | 1.02 ± 0.11 | 3.90 ± 0.53 | 282.35 | 2.43 |  |  |  |
CK (UI/L) | ET | 95.1 ± 15.7 | 184.3 ± 32.1 | 93.9 | 6.91 | < 0.001(3.66) | 0.06(0.84) | 0.026(1.00) |
|  | NMT | 98.5 ± 20.8 | 148.3 ± 38.9 | 50.6 | 7.50 |  |  |  |
LDH (UI/L) | ET | 99.6 ± 18.0 | 209.4 ± 25.9 | 110.3 | 10.22 | < 0.001(3.77) | 0.016(1.12) | 0.003(1.44) |
|  | NMT | 105.4 ± 16.6 | 168.1 ± 31.9 | 59.4 | 9.73 |  |  |  |